<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32422969</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3464</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21103464</ELocationID><Abstract><AbstractText>Beyond traditional approaches in understanding amyotrophic lateral sclerosis (ALS), multiple recent studies in RNA-binding proteins (RBPs)-including transactive response DNA-binding protein (TDP-43) and fused in sarcoma (FUS)-have instigated an interest in their function and prion-like properties. Given their prominence as hallmarks of a highly heterogeneous disease, this prompts a re-examination of the specific functional interrelationships between these proteins, especially as pathological SOD1-a non-RBP commonly associated with familial ALS (fALS)-exhibits similar properties to these RBPs including potential RNA-regulatory capabilities. Moreover, the cytoplasmic mislocalization, aggregation, and co-aggregation of TDP-43, FUS, and SOD1 can be identified as proteinopathies akin to other neurodegenerative diseases (NDs), eliciting strong ties to disrupted RNA splicing, transport, and stability. In recent years, microRNAs (miRNAs) have also been increasingly implicated in the disease, and are of greater significance as they are the master regulators of RNA metabolism in disease pathology. However, little is known about the role of these proteins and how they are regulated by miRNA, which would provide mechanistic insights into ALS pathogenesis. This review seeks to discuss current developments across TDP-43, FUS, and SOD1 to build a detailed snapshot of the network pathophysiology underlying ALS while aiming to highlight possible novel therapeutic targets to guide future research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Jade</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4348-495X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, The University of New South Wales, Kensington, Sydney, NSW 2033, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keon</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iggy Get Out, Neurodegenerative Disease Section, Darlinghurst, Sydney, NSW 2010, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Iggy Get Out, Neurodegenerative Disease Section, Darlinghurst, Sydney, NSW 2010, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saksena</LastName><ForeName>Nitin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Iggy Get Out, Neurodegenerative Disease Section, Darlinghurst, Sydney, NSW 2010, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012326" MajorTopicYN="N">RNA Splicing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">RNA metabolism</Keyword><Keyword MajorTopicYN="N">RNA-binding proteins</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32422969</ArticleId><ArticleId IdType="pmc">PMC7278980</ArticleId><ArticleId IdType="doi">10.3390/ijms21103464</ArticleId><ArticleId IdType="pii">ijms21103464</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conlon E.G., Fagegaltier D., Agius P., Davis-Porada J., Gregory J., Hubbard I., Kang K., Kim D., Phatnani H., Shneider N.A. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife. 2018;7:e37754. doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Robberecht W., Van Den Bosch L. Modelling amyotrophic lateral sclerosis: Progress and possibilities. Dis. Models Mech. 2017;10:537&#x2013;549. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu E.Y., Cali C.P., Lee E.B. RNA metabolism in neurodegenerative disease. Dis. Models Mech. 2017;10:509&#x2013;518. doi: 10.1242/dmm.028613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.028613</ArticleId><ArticleId IdType="pmc">PMC5451173</ArticleId><ArticleId IdType="pubmed">28468937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS genetics, mechanisms, and therapeutics: Where are we now? Front. Neurosci. 2019;13 doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Kim J.R., Van Bruggen R., Park J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol. Cells. 2018;41:818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon G.S., Shim Y.-M., Lee D.-Y., Kim J.-S., Kang M., Ahn S.H., Shin J.-Y., Geum D., Hong Y.H., Sung J.-J. Pathological modification of TDP-43 in amyotrophic lateral sclerosis with SOD1 mutations. Mol. Neurobiol. 2019;56:2007&#x2013;2021. doi: 10.1007/s12035-018-1218-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1218-2</ArticleId><ArticleId IdType="pmc">PMC6394608</ArticleId><ArticleId IdType="pubmed">29982983</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi H., Kato S., Mochimaru Y., Fujimura H., Etoh M., Sakoda S. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2009;68:37&#x2013;47. doi: 10.1097/NEN.0b013e3181919cb5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181919cb5</ArticleId><ArticleId IdType="pubmed">19104447</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto Y., Ihara M., Urushitani M., Yamashita H., Kondo T., Tanigaki A., Oono M., Kawamata J., Ikemoto A., Kawamoto Y. An autopsy case of SOD1-related ALS with TDP-43 positive inclusions. Neurology. 2011;77:1993&#x2013;1995. doi: 10.1212/WNL.0b013e31823a0cfc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31823a0cfc</ArticleId><ArticleId IdType="pubmed">22094482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Zollino M., Conte A., Del Grande A., Marangi G., Lucchini M., Mirabella M., Romano A., Piacentini R., Bisogni G. Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations. Neurobiol. Aging. 2015;36:2005.e5&#x2013;2005.e13. doi: 10.1016/j.neurobiolaging.2015.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.009</ArticleId><ArticleId IdType="pubmed">25792239</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., De Assis D.R., Vourc&#x2019;h P., Andres C.R., Corcia P., Lanznaster D., Blasco H. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: A resolution in sight? Brain. 2019;142:1176&#x2013;1194. doi: 10.1093/brain/awz078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Sidle K.C.L., Hardy J. Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS) Neuropathol. Appl. Neurobiol. 2015;41:578&#x2013;597. doi: 10.1111/nan.12206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12206</ArticleId><ArticleId IdType="pubmed">25487060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C., Zhang Y.-J., Xu Y.-F., Dickson D.W., Petrucelli L. TDP-43 in neurodegenerative disorders. Expert Opin. Biol. Ther. 2008;8:969&#x2013;978. doi: 10.1517/14712598.8.7.969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.8.7.969</ArticleId><ArticleId IdType="pmc">PMC2855963</ArticleId><ArticleId IdType="pubmed">18549326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.R., King O.D., Shorter J., Gitler A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013;201:361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Arisi I., D&#x2019;Ambrosi N., Storti A., Brandi R., D&#x2019;Onofrio M., Volonte C. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis. 2013;4:e959. doi: 10.1038/cddis.2013.491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.491</ArticleId><ArticleId IdType="pmc">PMC3877562</ArticleId><ArticleId IdType="pubmed">24336079</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Le Masson G. RNA-targeted therapies and amyotrophic lateral sclerosis. Biomedicines. 2018;6:9. doi: 10.3390/biomedicines6010009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines6010009</ArticleId><ArticleId IdType="pmc">PMC5874666</ArticleId><ArticleId IdType="pubmed">29342921</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan C., Hornstein E. Vulnerability of microRNA biogenesis in FTD&#x2013;ALS. Brain Res. 2016;1647:105&#x2013;111. doi: 10.1016/j.brainres.2015.12.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.12.063</ArticleId><ArticleId IdType="pubmed">26778173</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahid F., Shehzad A., Khan T., Kim Y.Y. MicroRNAs: Synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2010;1803:1231&#x2013;1243. doi: 10.1016/j.bbamcr.2010.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2010.06.013</ArticleId><ArticleId IdType="pubmed">20619301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. USA. 2012;109:3347&#x2013;3352. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.-X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw C., Enayat Z., Chioza B., Al-Chalabi A., Radunovic A., Powell J., Leigh P. Mutations in all five exons of SOD-1 may cause ALS. Ann. Neurol. 1998;43:390&#x2013;394. doi: 10.1002/ana.410430319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410430319</ArticleId><ArticleId IdType="pubmed">9506558</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Traynor B.J., Lombardo F., Fimognari M., Calvo A., Ghiglione P., Mutani R., Restagno G. Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 2008;70:533. doi: 10.1212/01.wnl.0000299187.90432.3f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000299187.90432.3f</ArticleId><ArticleId IdType="pubmed">18268245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K., Barmada S.J. TDP43 and RNA instability in amyotrophic lateral sclerosis. Brain Res. 2018;1693:67&#x2013;74. doi: 10.1016/j.brainres.2018.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.01.015</ArticleId><ArticleId IdType="pmc">PMC5997512</ArticleId><ArticleId IdType="pubmed">29395044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., Hannon G., Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317:1220&#x2013;1224. doi: 10.1126/science.1140481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1140481</ArticleId><ArticleId IdType="pmc">PMC2782470</ArticleId><ArticleId IdType="pubmed">17761882</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina P.P., Slack F.J. microRNAs and cancer: An overview. Cell Cycle. 2008;7:2485&#x2013;2492. doi: 10.4161/cc.7.16.6453.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.7.16.6453</ArticleId><ArticleId IdType="pubmed">18719380</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Lunn J.S., Paez-Colasante X., Bender D.E., Yung R., Sakowski S.A., Feldman E.L. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol. Cell. Neurosci. 2016;71:34&#x2013;45. doi: 10.1016/j.mcn.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014;15:509&#x2013;524. doi: 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambros V. microRNAs: Tiny regulators with great potential. Cell. 2001;107:823&#x2013;826. doi: 10.1016/S0092-8674(01)00616-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00616-X</ArticleId><ArticleId IdType="pubmed">11779458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagos-Quintana M., Rauhut R., Meyer J., Borkhardt A., Tuschl T. New microRNAs from mouse and human. RNA. 2003;9:175&#x2013;179. doi: 10.1261/rna.2146903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2146903</ArticleId><ArticleId IdType="pmc">PMC1370382</ArticleId><ArticleId IdType="pubmed">12554859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853&#x2013;858. doi: 10.1126/science.1064921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1064921</ArticleId><ArticleId IdType="pubmed">11679670</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L.P., Glasner M.E., Yekta S., Burge C.B., Bartel D.P. Vertebrate microRNA genes. Science. 2003;299:1540. doi: 10.1126/science.1080372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1080372</ArticleId><ArticleId IdType="pubmed">12624257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X., Hagedorn C.H., Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA. 2004;10:1957&#x2013;1966. doi: 10.1261/rna.7135204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.7135204</ArticleId><ArticleId IdType="pmc">PMC1370684</ArticleId><ArticleId IdType="pubmed">15525708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004;23:4051&#x2013;4060. doi: 10.1038/sj.emboj.7600385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600385</ArticleId><ArticleId IdType="pmc">PMC524334</ArticleId><ArticleId IdType="pubmed">15372072</ArticleId></ArticleIdList></Reference><Reference><Citation>Partin A.C., Ngo T.D., Herrell E., Jeong B.-C., Hon G., Nam Y. Heme enables proper positioning of Drosha and DGCR8 on primary microRNAs. Nat. Commun. 2017;8:1&#x2013;10. doi: 10.1038/s41467-017-01713-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01713-y</ArticleId><ArticleId IdType="pmc">PMC5700927</ArticleId><ArticleId IdType="pubmed">29170488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., R&#xe5;dmark O., Kim S. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415&#x2013;419. doi: 10.1038/nature01957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01957</ArticleId><ArticleId IdType="pubmed">14508493</ArticleId></ArticleIdList></Reference><Reference><Citation>Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature. 2004;432:231&#x2013;235. doi: 10.1038/nature03049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03049</ArticleId><ArticleId IdType="pubmed">15531879</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory R.I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature. 2004;432:235&#x2013;240. doi: 10.1038/nature03120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03120</ArticleId><ArticleId IdType="pubmed">15531877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund E., G&#xfc;ttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science. 2004;303:95&#x2013;98. doi: 10.1126/science.1090599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1090599</ArticleId><ArticleId IdType="pubmed">14631048</ArticleId></ArticleIdList></Reference><Reference><Citation>Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740&#x2013;744. doi: 10.1038/nature03868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03868</ArticleId><ArticleId IdType="pmc">PMC2944926</ArticleId><ArticleId IdType="pubmed">15973356</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.-J., Hammond S.M., Joshua-Tor L., Hannon G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004;305:1437&#x2013;1441. doi: 10.1126/science.1102513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1102513</ArticleId><ArticleId IdType="pubmed">15284456</ArticleId></ArticleIdList></Reference><Reference><Citation>Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell. 2004;15:185&#x2013;197. doi: 10.1016/j.molcel.2004.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2004.07.007</ArticleId><ArticleId IdType="pubmed">15260970</ArticleId></ArticleIdList></Reference><Reference><Citation>Doench J.G., Sharp P.A. Specificity of microRNA target selection in translational repression. Genes Dev. 2004;18:504&#x2013;511. doi: 10.1101/gad.1184404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1184404</ArticleId><ArticleId IdType="pmc">PMC374233</ArticleId><ArticleId IdType="pubmed">15014042</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll A.P., Tooney P.A., Cairns M.J. Context-specific microRNA function in developmental complexity. J. Mol. Cell Biol. 2013;5:73&#x2013;84. doi: 10.1093/jmcb/mjt004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjt004</ArticleId><ArticleId IdType="pubmed">23362311</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Cenik B., Cenik B.K., Herz J., Yu G. TDP-43 in central nervous system development and function: Clues to TDP-43-associated neurodegeneration. Biol. Chem. 2012;393:589&#x2013;594. doi: 10.1515/hsz-2012-0115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2012-0115</ArticleId><ArticleId IdType="pmc">PMC3537500</ArticleId><ArticleId IdType="pubmed">22944662</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A. TDP-43 depletion: Mechanism of neuronal cell death in ALS. Future Neurol. 2018;13:143&#x2013;149. doi: 10.2217/fnl-2018-0010.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fnl-2018-0010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F., Tada M., Kon T., Miki Y., Tanji K., Kurotaki H., Tomiyama M., Ishihara T., Onodera O., Kakita A., et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol. Commun. 2019;7:165. doi: 10.1186/s40478-019-0824-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0824-1</ArticleId><ArticleId IdType="pmc">PMC6816170</ArticleId><ArticleId IdType="pubmed">31661037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski M.D., Dickson D.W., Powell S.Z., Arumanayagam A.S., Rivera A.L., Appel S.H. Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion. Acta Neuropathol. 2019;138:667&#x2013;670. doi: 10.1007/s00401-019-02050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02050-8</ArticleId><ArticleId IdType="pmc">PMC6778061</ArticleId><ArticleId IdType="pubmed">31375896</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning B.A., Walker A.K. The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD. Front. Neurosci. 2019;13:335. doi: 10.3389/fnins.2019.00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2019;12 doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Guerrero E.N., Hegde P.M., Liachko N.F., Wang H., Vasquez V., Gao J., Pandey A., Taylor J.P., Kraemer B.C., et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc. Natl. Acad. Sci. USA. 2019;116:4696&#x2013;4705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo V., Grossi E., Laneve P., Morlando M., Modigliani S.D., Ballarino M., Bozzoni I., Caffarelli E. TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation. Mol. Neurobiol. 2013;48:952&#x2013;963. doi: 10.1007/s12035-013-8564-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8564-x</ArticleId><ArticleId IdType="pubmed">24113842</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Xu Y.-F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.-L., Tong J., Castanedes-Casey M., Ash P. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2009;106:7607&#x2013;7612. doi: 10.1073/pnas.0900688106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Kametani F., Arai T., Akiyama H., Hasegawa M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 2009;18:3353&#x2013;3364. doi: 10.1093/hmg/ddp275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp275</ArticleId><ArticleId IdType="pubmed">19515851</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., McCaffery J.M., Lindquist S., Gitler A.D. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2008;105:6439&#x2013;6444. doi: 10.1073/pnas.0802082105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M., Johnson B.S., King O.D., Gitler A.D., Shorter J. Prion-like disorders: Blurring the divide between transmissibility and infectivity. J. Cell Sci. 2010;123:1191&#x2013;1201. doi: 10.1242/jcs.051672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.051672</ArticleId><ArticleId IdType="pmc">PMC2848109</ArticleId><ArticleId IdType="pubmed">20356930</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Hideyama T., Hachiga K., Teramoto S., Takano J., Iwata N., Saido T.C., Kwak S. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 2012;3:1307. doi: 10.1038/ncomms2303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2303</ArticleId><ArticleId IdType="pubmed">23250437</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N.H., Smith R.B., Carrasco M.A., Williams L.A., Winborn C.S., Han S.S., Kiskinis E., Winborn B., Freibaum B.D., Kanagaraj A. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., De Conti L., Stuani C., Romano M., Baralle M., Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277:2268&#x2013;2281. doi: 10.1111/j.1742-4658.2010.07643.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07643.x</ArticleId><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Almeida S., Lu Y., Nishimura A.L., Peng L., Sun D., Wu B., Karydas A.M., Tartaglia M.C., Fong J.C. Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations. PLoS ONE. 2013;8:e76055. doi: 10.1371/journal.pone.0076055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076055</ArticleId><ArticleId IdType="pmc">PMC3797144</ArticleId><ArticleId IdType="pubmed">24143176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinar A., Ravnik-Glava&#x10d; M., Glava&#x10d; D. Epigenetic mechanisms in amyotrophic lateral sclerosis: A short review. Mech. Ageing Dev. 2018;174:103&#x2013;110. doi: 10.1016/j.mad.2018.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2018.03.005</ArticleId><ArticleId IdType="pubmed">29545202</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A., Eitan C., Liou L.L., Libby R.T., Rivkin N., Magen I., Reichenstein I., Oppenheim H., Eilam R., Silvestroni A. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: A new mechanism for ALS. EMBO J. 2015;34:2633&#x2013;2651. doi: 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D., Leclerc A., Tamrazian E., Vanderburg C., Russ C., Davis A., Gilchrist J., Kasarskis E., Munsat T. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M., Igaz L., Wong M., Kwong L., Trojanowski J., Lee V. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.M800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads S.N., Monahan Z.T., Yee D.S., Leung A.Y., Newcombe C.G., O&#x2019;Meally R.N., Cole R.N., Shewmaker F.P. The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. Mol. Biol. Cell. 2018;29:1786&#x2013;1797. doi: 10.1091/mbc.E17-12-0735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-12-0735</ArticleId><ArticleId IdType="pmc">PMC6085830</ArticleId><ArticleId IdType="pubmed">29897835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangoumau A., Veyrat-Durebex C., Blasco H., Praline J., Corcia P., Andres C.R., Vourc&#x2019;h P. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. Int. J. Neurosci. 2013;123:366&#x2013;374. doi: 10.3109/00207454.2012.761984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2012.761984</ArticleId><ArticleId IdType="pubmed">23289752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Sobue G. Importance of functional loss of FUS in FTLD/ALS. Front. Mol. Biosci. 2018;5:44. doi: 10.3389/fmolb.2018.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2018.00044</ArticleId><ArticleId IdType="pmc">PMC5943504</ArticleId><ArticleId IdType="pubmed">29774215</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda A., Takeda J.-I., Okuno T., Okamoto T., Ohkawara B., Ito M., Ishigaki S., Sobue G., Ohno K. Position-specific binding of FUS to nascent RNA regulates mRNA length. Genes Dev. 2015;29:1045&#x2013;1057. doi: 10.1101/gad.255737.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.255737.114</ArticleId><ArticleId IdType="pmc">PMC4441052</ArticleId><ArticleId IdType="pubmed">25995189</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa T., Fujioka Y., Tanaka M., Honda D., Yokoi S., Riku Y., Ibi D., Nagai T., Yamada K., Watanabe H., et al. FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization. Nat. Commun. 2015;6:7098. doi: 10.1038/ncomms8098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8098</ArticleId><ArticleId IdType="pmc">PMC4479014</ArticleId><ArticleId IdType="pubmed">25968143</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoi S., Udagawa T., Fujioka Y., Honda D., Okado H., Watanabe H., Katsuno M., Ishigaki S., Sobue G. 3&#x2032; UTR length-dependent control of SynGAP isoform &#x3b1;2 mRNA by FUS and ELAV-like proteins promotes dendritic spine maturation and cognitive function. Cell Rep. 2017;20:3071&#x2013;3084. doi: 10.1016/j.celrep.2017.08.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.08.100</ArticleId><ArticleId IdType="pubmed">28954225</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateishi T., Hokonohara T., Yamasaki R., Miura S., Kikuchi H., Iwaki A., Tashiro H., Furuya H., Nagara Y., Ohyagi Y., et al. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol. 2010;119:355&#x2013;364. doi: 10.1007/s00401-009-0621-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0621-1</ArticleId><ArticleId IdType="pubmed">19967541</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M., Mikami H., Watanabe T., Yamano T., Yamazaki T., Nomura M., Yasui K., Ishikawa H., Ono S. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol. Scand. 2010;122:367&#x2013;372. doi: 10.1111/j.1600-0404.2010.01321.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2010.01321.x</ArticleId><ArticleId IdType="pubmed">20175762</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M., Modigliani S.D., Torrelli G., Rosa A., Di Carlo V., Caffarelli E., Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012;31:4502&#x2013;4510. doi: 10.1038/emboj.2012.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.319</ArticleId><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Wu Y.-C., Mullane P., Ji Y.J., Liu H., He L., Arora A., Hwang H.-Y., Alessi A.F., Niaki A.G. FUS regulates activity of MicroRNA-mediated gene silencing. Mol. Cell. 2018;69:787&#x2013;801.e8. doi: 10.1016/j.molcel.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.001</ArticleId><ArticleId IdType="pmc">PMC5836505</ArticleId><ArticleId IdType="pubmed">29499134</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Skelt L., Notaro A., Highley J.R., Fox A.H., La Bella V., Buchman V.L., Shelkovnikova T.A. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol. Commun. 2019;7:1&#x2013;14. doi: 10.1186/s40478-019-0658-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0658-x</ArticleId><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R., Santini L., Colantoni A., Peruzzi G., De Turris V., Alfano V., Bozzoni I., Rosa A. FUS mutant human motoneurons display altered transcriptome and microRNA pathways with implications for ALS pathogenesis. Stem Cell Rep. 2017;9:1450&#x2013;1462. doi: 10.1016/j.stemcr.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A., Namboori S.C., Bithell A., Soldati C., Buckley N.J., Stanton L.W. Mir-375 is essential for human spinal motor neuron development and may be involved in motor neuron degeneration. Stem Cells. 2016;34:124&#x2013;134. doi: 10.1002/stem.2233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2233</ArticleId><ArticleId IdType="pubmed">26507573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat M.A., Onori A., Toselli C., Stronati E., Morlando M., Bozzoni I., Monni E., Kokaia Z., Lupo G., Minghetti L. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci. Rep. 2019;9:1&#x2013;15. doi: 10.1038/s41598-019-41040-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41040-4</ArticleId><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>McCord J.M., Fridovich I. Superoxide dismutase an enzymic function for erythrocuprein (hemocuprein) J. Biol. Chem. 1969;244:6049&#x2013;6055.</Citation><ArticleIdList><ArticleId IdType="pubmed">5389100</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Bordoni M., Diamanti L., Sproviero D., Gagliardi S., Cereda C. SOD1 in amyotrophic lateral sclerosis:&#x201c;ambivalent&#x201d; behavior connected to the disease. Int. J. Mol. Sci. 2018;19:1345. doi: 10.3390/ijms19051345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pmc">PMC5983710</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D.A., Trotti D., Pasinelli P. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA. 2012;109:5074&#x2013;5079. doi: 10.1073/pnas.1115402109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C., O&#x2019;Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. USA. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Pokrishevsky E., Silverman J.M., Cashman N.R. Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding. Prion. 2014;8:331&#x2013;335. doi: 10.4161/19336896.2014.983398.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/19336896.2014.983398</ArticleId><ArticleId IdType="pmc">PMC4601269</ArticleId><ArticleId IdType="pubmed">25551548</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Cleveland D.W. Prion-like spread of protein aggregates in neurodegeneration. J. Exp. Med. 2012;209:889&#x2013;893. doi: 10.1084/jem.20120741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20120741</ArticleId><ArticleId IdType="pmc">PMC3348110</ArticleId><ArticleId IdType="pubmed">22566400</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Hare D.J., Double K.L. A proposed mechanism for neurodegeneration in movement disorders characterized by metal dyshomeostasis and oxidative stress. Cell Chem. Biol. 2018;25:807&#x2013;816. doi: 10.1016/j.chembiol.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2018.05.004</ArticleId><ArticleId IdType="pubmed">29861271</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Davies K.M., Cottam V., Genoud S., Ortega R., Roudeau S., Carmona A., De Silva K., Wasinger V., Lewis S.J. Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson&#x2019;s disease brain. Acta Neuropathol. 2017;134:113&#x2013;127. doi: 10.1007/s00401-017-1726-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1726-6</ArticleId><ArticleId IdType="pubmed">28527045</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Fifita J.A., Freckleton S.E., Hare D.J., Lewis S.J., Halliday G.M., Blair I.P., Double K.L. Accumulation of dysfunctional SOD1 protein in Parkinson&#x2019;s disease is not associated with mutations in the SOD1 gene. Acta Neuropathol. 2018;135:155&#x2013;156. doi: 10.1007/s00401-017-1779-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1779-6</ArticleId><ArticleId IdType="pubmed">29052003</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Boca M., Girotto S., Martinelli M., Valentine J.S., Vieru M. SOD1 and amyotrophic lateral sclerosis: Mutations and oligomerization. PLoS ONE. 2008;3:e1677. doi: 10.1371/journal.pone.0001677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001677</ArticleId><ArticleId IdType="pmc">PMC2250751</ArticleId><ArticleId IdType="pubmed">18301754</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Durazo A., Girotto S., Gralla E.B., Martinelli M., Valentine J.S., Vieru M., Whitelegge J.P. Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS. Proc. Natl. Acad. Sci. USA. 2007;104:11263&#x2013;11267. doi: 10.1073/pnas.0704307104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0704307104</ArticleId><ArticleId IdType="pmc">PMC1899188</ArticleId><ArticleId IdType="pubmed">17592131</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., O&#x2019;Halloran T.V. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo-and reduced form of SOD1, leading to unfolding and oxidative aggregation. J. Biol. Chem. 2005;280:17266&#x2013;17274. doi: 10.1074/jbc.M500482200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500482200</ArticleId><ArticleId IdType="pubmed">15691826</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.-F., Crow J.P., Cashman N.R., Kondejewski L.H., Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 2002;277:47551&#x2013;47556. doi: 10.1074/jbc.M207356200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207356200</ArticleId><ArticleId IdType="pubmed">12356748</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt N.D., Agar J.N. Parsing disease-relevant protein modifications from epiphenomena: Perspective on the structural basis of SOD1-mediated ALS. J. Mass Spectrom. 2017;52:480&#x2013;491. doi: 10.1002/jms.3953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.3953</ArticleId><ArticleId IdType="pmc">PMC6002871</ArticleId><ArticleId IdType="pubmed">28558143</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B.A., Volkening K., Droppelmann C.A., Ang L.C., Rademakers R., Strong M.J. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: Evidence of a common pathogenic mechanism. Acta Neuropathol. 2012;124:733&#x2013;747. doi: 10.1007/s00401-012-1035-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1035-z</ArticleId><ArticleId IdType="pubmed">22941224</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunton-Stasyshyn R.K., Saccon R.A., Fratta P., Fisher E.M. SOD1 function and its implications for amyotrophic lateral sclerosis pathology: New and renascent themes. Neuroscientist. 2015;21:519&#x2013;529. doi: 10.1177/1073858414561795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858414561795</ArticleId><ArticleId IdType="pubmed">25492944</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2019;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Konovalova J., Gerasymchuk D., Parkkinen I., Chmielarz P., Domanskyi A. Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases. Int. J. Mol. Sci. 2019;20:6055. doi: 10.3390/ijms20236055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20236055</ArticleId><ArticleId IdType="pmc">PMC6929013</ArticleId><ArticleId IdType="pubmed">31801298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioya M., Obayashi S., Tabunoki H., Arima K., Saito Y., Ishida T., Satoh J.-I. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 2010;36:320&#x2013;330. doi: 10.1111/j.1365-2990.2010.01076.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2010.01076.x</ArticleId><ArticleId IdType="pubmed">20202123</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Goodall E.F., Milo M., Cooper-Knock J., Da Costa M., Hobson E., Kazoka M., Wollff H., Heath P.R., Shaw P.J. Serum miRNAs miR-206, 143&#x2013;3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol. Aging. 2017;55:123&#x2013;131. doi: 10.1016/j.neurobiolaging.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., Zhang L., Lu Y., Zhang M., Zhang Z., Wang K., Lv J. Down-regulation of microRNA-142-5p attenuates oxygen-glucose deprivation and reoxygenation-induced neuron injury through up-regulating Nrf2/ARE signaling pathway. Biomed. Pharmacother. 2017;89:1187&#x2013;1195. doi: 10.1016/j.biopha.2017.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.03.011</ArticleId><ArticleId IdType="pubmed">28320085</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval E.D., Shaner C., Zhang P., Du Maine X., Fischer K., Tay J., Chau B.N., Wu G.F., Miller T.M. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet. 2013;22:4127&#x2013;4135. doi: 10.1093/hmg/ddt261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt261</ArticleId><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Paladino S., Conte A., Caggiano R., Pierantoni G.M., Faraonio R. Nrf2 pathway in age-related neurological disorders: Insights into MicroRNAs. Cell. Physiol. Biochem. 2018;47:1951&#x2013;1976. doi: 10.1159/000491465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000491465</ArticleId><ArticleId IdType="pubmed">29969760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba Q., Cui C., Wen L., Feng S., Zhou J., Yang K. Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson&#x2019;s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway. Biomed. Pharmacother. 2015;75:165&#x2013;172. doi: 10.1016/j.biopha.2015.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2015.07.034</ArticleId><ArticleId IdType="pubmed">26282218</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong R., Wang Z., Zhao Z., Li H., Chen W., Zhang B., Wang L., Wu L., Li W., Ding J. MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration. Neurobiol. Aging. 2014;35:705&#x2013;714. doi: 10.1016/j.neurobiolaging.2013.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.027</ArticleId><ArticleId IdType="pubmed">24269020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabaria S., Choi D.C., Chaudhuri A.D., Jain M.R., Li H., Junn E. MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression. Free Radic. Biol. Med. 2015;89:548&#x2013;556. doi: 10.1016/j.freeradbiomed.2015.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.09.010</ArticleId><ArticleId IdType="pmc">PMC4684759</ArticleId><ArticleId IdType="pubmed">26453926</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasimhan M., Patel D., Vedpathak D., Rathinam M., Henderson G., Mahimainathan L. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS ONE. 2012;7:e51111. doi: 10.1371/journal.pone.0051111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051111</ArticleId><ArticleId IdType="pmc">PMC3517581</ArticleId><ArticleId IdType="pubmed">23236440</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D., De Biasi S., Vitellaro-Zuccarello L., Riso P., Guarnieri S., Porrini M., Simeoni S., Crippa V., Onesto E., Palazzolo I. Mutation of SOD1 in ALS: A gain of a loss of function. Hum. Mol. Genet. 2007;16:1604&#x2013;1618. doi: 10.1093/hmg/ddm110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm110</ArticleId><ArticleId IdType="pubmed">17504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A., Leonardis L., Zidar J., Koritnik B., Dolenc-Groselj L., Kovacic S.R., Curk T., Rogelj B. Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci. Rep. 2018;8:1&#x2013;15. doi: 10.1038/s41598-018-23139-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23139-2</ArticleId><ArticleId IdType="pmc">PMC5884852</ArticleId><ArticleId IdType="pubmed">29618798</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R., Regev K., Healy B.C., Mazzola M.A., Beynon V., Von Glehn F., Paul A., Diaz-Cruz C., Gholipour T., Glanz B.I. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:261&#x2013;269. doi: 10.1002/mus.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A.P., Ghobrial L., Ngo S., Yerbury J., Zacharewicz E., Chung R., Lamon S. Dysregulation of microRNA biogenesis machinery and microRNA/RNA ratio in skeletal muscle of amyotrophic lateral sclerosis mice. Muscle Nerve. 2018;57:838&#x2013;847. doi: 10.1002/mus.26039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26039</ArticleId><ArticleId IdType="pubmed">29236291</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Jedrychowski M.P., Cialic R., Krasemann S., Murugaiyan G., Fanek Z., Greco D.J., Wu P.M., Doykan C.E., Kiner O. Targeting mi R-155 restores abnormal microglia and attenuates disease in SOD 1 mice. Ann. Neurol. 2015;77:75&#x2013;99. doi: 10.1002/ana.24304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye M.L., Koval E.D., Wegener A.J., Hyman T.S., Yang C., O&#x2019;Brien D.R., Miller R.L., Cole T., Schoch K.M., Shen T. MicroRNA profiling reveals marker of motor neuron disease in ALS models. J. Neurosci. 2017;37:5574&#x2013;5586. doi: 10.1523/JNEUROSCI.3582-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3582-16.2017</ArticleId><ArticleId IdType="pmc">PMC5452343</ArticleId><ArticleId IdType="pubmed">28416596</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstr&#xf6;m P., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Marklund S.L. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J. Neurochem. 2011;117:91&#x2013;99. doi: 10.1111/j.1471-4159.2011.07177.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07177.x</ArticleId><ArticleId IdType="pubmed">21226712</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Kuang L., Barnett K.R., Zhu B.Z., Shissler S.C., Korotkov K.V., Hayward L.J., Kasarskis E.J., Zhu H. ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics. Acta Neuropathol. 2016;132:563&#x2013;576. doi: 10.1007/s00401-016-1601-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1601-x</ArticleId><ArticleId IdType="pmc">PMC5023729</ArticleId><ArticleId IdType="pubmed">27481264</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan S., Keon M., Liu B., Su Z., Saksena N.K. Panoramic visualization of circulating microRNAs across neurodegenerative diseases in humans. Mol. Neurobiol. 2019;56:7380&#x2013;7407. doi: 10.1007/s12035-019-1615-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1615-1</ArticleId><ArticleId IdType="pmc">PMC6815273</ArticleId><ArticleId IdType="pubmed">31037649</ArticleId></ArticleIdList></Reference><Reference><Citation>King O.D., Gitler A.D., Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61&#x2013;80. doi: 10.1016/j.brainres.2012.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.016</ArticleId><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J., Yeo G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum. Genet. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Treiber T., Treiber N., Plessmann U., Harlander S., Dai&#xdf; J.-L., Eichner N., Lehmann G., Schall K., Urlaub H., Meister G. A compendium of RNA-binding proteins that regulate microRNA biogenesis. Mol. Cell. 2017;66:270&#x2013;284.e13. doi: 10.1016/j.molcel.2017.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.03.014</ArticleId><ArticleId IdType="pubmed">28431233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., Cleveland D.W. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. USA. 2010;107:13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D., Wickner R.B., Shewmaker F. FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis. Protein Cell. 2011;2:223&#x2013;236. doi: 10.1007/s13238-011-1525-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1525-0</ArticleId><ArticleId IdType="pmc">PMC4875312</ArticleId><ArticleId IdType="pubmed">21452073</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E., Grad L.I., Cashman N.R. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Sci. Rep. 2016;6:22155. doi: 10.1038/srep22155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22155</ArticleId><ArticleId IdType="pmc">PMC4772009</ArticleId><ArticleId IdType="pubmed">26926802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin G., Mao D., Bellen H. Current Topics in Developmental Biology. Volume 121. Elsevier; Amsterdam, The Netherlands: 2017. Amyotrophic lateral sclerosis pathogenesis converges on defects in protein homeostasis associated with TDP-43 mislocalization and proteasome-mediated degradation overload; pp. 111&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">28057298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Bercier V., Lissouba A., Liao M., Brustein E., Rouleau G.A., Drapeau P. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet. 2011;7:e1002214. doi: 10.1371/journal.pgen.1002214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002214</ArticleId><ArticleId IdType="pmc">PMC3150442</ArticleId><ArticleId IdType="pubmed">21829392</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P., Coller H. Functional interactions between microRNAs and RNA binding proteins. MicroRNA. 2012;1:70&#x2013;79. doi: 10.2174/2211536611201010070.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2211536611201010070</ArticleId><ArticleId IdType="pmc">PMC5123774</ArticleId><ArticleId IdType="pubmed">25048093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wienholds E., Kloosterman W.P., Miska E., Alvarez-Saavedra E., Berezikov E., De Bruijn E., Horvitz H.R., Kauppinen S., Plasterk R.H. MicroRNA expression in zebrafish embryonic development. Science. 2005;309:310&#x2013;311. doi: 10.1126/science.1114519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1114519</ArticleId><ArticleId IdType="pubmed">15919954</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435:839&#x2013;843. doi: 10.1038/nature03677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03677</ArticleId><ArticleId IdType="pubmed">15944709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Liu S., Liu G., &#xd6;zt&#xfc;rk A., Hicks G.G. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9:e1003895. doi: 10.1371/journal.pgen.1003895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003895</ArticleId><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugai A., Kato T., Koyama A., Koike Y., Kasahara S., Konno T., Ishihara T., Onodera O. Robustness and vulnerability of the autoregulatory system that maintains nuclear TDP-43 levels: A trade-off hypothesis for als pathology based on in silico data. Front. Neurosci. 2018;12:28. doi: 10.3389/fnins.2018.00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00028</ArticleId><ArticleId IdType="pmc">PMC5799296</ArticleId><ArticleId IdType="pubmed">29449800</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerner A.C., Frottin F., Hornburg D., Feng L.R., Meissner F., Patra M., Tatzelt J., Mann M., Winklhofer K.F., Hartl F.U. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 2016;351:173&#x2013;176. doi: 10.1126/science.aad2033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2033</ArticleId><ArticleId IdType="pubmed">26634439</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C., Deisel J., Aufschnaiter A., Ambros S., Tereshchenko M., Verheijen B.M., B&#xfc;ttner S., Braun R.J. Endolysosomal pathway activity protects cells from neurotoxic TDP-43. Microb. Cell. 2018;5:212&#x2013;214. doi: 10.15698/mic2018.04.627.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/mic2018.04.627</ArticleId><ArticleId IdType="pmc">PMC5878689</ArticleId><ArticleId IdType="pubmed">29611555</ArticleId></ArticleIdList></Reference><Reference><Citation>Filimonenko M., Stuffers S., Raiborg C., Yamamoto A., Maler&#xf8;d L., Fisher E.M., Isaacs A., Brech A., Stenmark H., Simonsen A. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 2007;179:485&#x2013;500. doi: 10.1083/jcb.200702115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200702115</ArticleId><ArticleId IdType="pmc">PMC2064794</ArticleId><ArticleId IdType="pubmed">17984323</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Chen H.-J., Shaw C.E. TDP-43 proteinopathy and ALS: Insights into disease mechanisms and therapeutic targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J.M., La Spada A.R. ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan J.R. mRNP granules: Assembly, function, and connections with disease. RNA Biol. 2014;11:1019&#x2013;1030. doi: 10.4161/15476286.2014.972208.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/15476286.2014.972208</ArticleId><ArticleId IdType="pmc">PMC4615263</ArticleId><ArticleId IdType="pubmed">25531407</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul S., Dansithong W., Figueroa K.P., Scoles D.R., Pulst S.M. Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration. Nat. Commun. 2018;9:1&#x2013;14. doi: 10.1038/s41467-018-06041-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06041-3</ArticleId><ArticleId IdType="pmc">PMC6128856</ArticleId><ArticleId IdType="pubmed">30194296</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., Goolsby H., Fontaine B.A., Lemay N., McKenna-Yasek D. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D., La Salvia S., Giannini M., Crippa V., Gagliardi S., Bernuzzi S., Diamanti L., Ceroni M., Pansarasa O., Poletti A. Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients. Front. Neurosci. 2018;12:487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Kukharsky M.S., An H., Dimasi P., Alexeeva S., Shabir O., Heath P.R., Buchman V.L. Protective paraspeckle hyper-assembly downstream of TDP-43 loss of function in amyotrophic lateral sclerosis. Mol. Neurodegener. 2018;13:30. doi: 10.1186/s13024-018-0263-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0263-7</ArticleId><ArticleId IdType="pmc">PMC5984788</ArticleId><ArticleId IdType="pubmed">29859124</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Restrepo C.R., Khan T., Dominique M.A., Fang T.C., Canter R.G., Roberts C.J., Miller K.R., Ransohoff R.M., Trojanowski J.Q. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim H.-J. Prion-like mechanism in amyotrophic lateral sclerosis: Are protein aggregates the key? Exp. Neurobiol. 2015;24:1&#x2013;7. doi: 10.5607/en.2015.24.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.1.1</ArticleId><ArticleId IdType="pmc">PMC4363329</ArticleId><ArticleId IdType="pubmed">25792864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond C.S., Fox A.H. Paraspeckles: Nuclear bodies built on long noncoding RNA. J. Cell Biol. 2009;186:637&#x2013;644. doi: 10.1083/jcb.200906113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200906113</ArticleId><ArticleId IdType="pmc">PMC2742191</ArticleId><ArticleId IdType="pubmed">19720872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig S., Kong G., Mannen T., Sadowska A., Kobelke S., Blythe A., Knott G.J., Iyer K.S., Ho D., Newcombe E.A. Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles. J. Cell Biol. 2015;210:529&#x2013;539. doi: 10.1083/jcb.201504117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504117</ArticleId><ArticleId IdType="pmc">PMC4539981</ArticleId><ArticleId IdType="pubmed">26283796</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Neumann M. Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol. 2017;134:79&#x2013;96. doi: 10.1007/s00401-017-1716-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1716-8</ArticleId><ArticleId IdType="pubmed">28466142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. Regulated protein aggregation: Stress granules and neurodegeneration. Mol. Neurodegener. 2012;7:56. doi: 10.1186/1750-1326-7-56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-56</ArticleId><ArticleId IdType="pmc">PMC3519755</ArticleId><ArticleId IdType="pubmed">23164372</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Shao C., Wu Q.-J., Chen G., Zhou J., Yang B., Li H., Gou L.-T., Zhang Y., Wang Y. NEAT1 scaffolds RNA-binding proteins and the microprocessor to globally enhance pri-miRNA processing. Nat. Struct. Mol. Biol. 2017;24:816&#x2013;824. doi: 10.1038/nsmb.3455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3455</ArticleId><ArticleId IdType="pmc">PMC5766049</ArticleId><ArticleId IdType="pubmed">28846091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Hu S.-B., Wang M.-R., Yao R.-W., Wu D., Yang L., Chen L.-L. Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat. Cell Biol. 2018;20:1145&#x2013;1158. doi: 10.1038/s41556-018-0204-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0204-2</ArticleId><ArticleId IdType="pubmed">30250064</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E., Grad L.I., Yousefi M., Wang J., Mackenzie I.R., Cashman N.R. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e35050. doi: 10.1371/journal.pone.0035050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035050</ArticleId><ArticleId IdType="pmc">PMC3320864</ArticleId><ArticleId IdType="pubmed">22493728</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.-F., Gendron T.F., Zhang Y.-J., Lin W.-L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Yang M., Chen Y., Chen X., Liu J., Sun S., Cheng H., Li Y., Bigio E.H., Mesulam M. FUS interacts with HSP60 to promote mitochondrial damage. PLoS Genet. 2015;11:e1005357. doi: 10.1371/journal.pgen.1005357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005357</ArticleId><ArticleId IdType="pmc">PMC4559378</ArticleId><ArticleId IdType="pubmed">26335776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787&#x2013;795. doi: 10.1038/nature05292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05292</ArticleId><ArticleId IdType="pubmed">17051205</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Kurisu J., Tateno M., Hatakeyama S., Nakayama K.I., Kato S., Takahashi R. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J. Neurochem. 2004;90:231&#x2013;244. doi: 10.1111/j.1471-4159.2004.02486.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02486.x</ArticleId><ArticleId IdType="pubmed">15198682</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulcahy L.A., Pink R.C., Carter D.R.F. Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles. 2014;3:24641. doi: 10.3402/jev.v3.24641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.24641</ArticleId><ArticleId IdType="pmc">PMC4122821</ArticleId><ArticleId IdType="pubmed">25143819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddine R., Farrawell N.E., Lambert-Smith I.A., Yerbury J.J. Addition of exogenous SOD1 aggregates causes TDP-43 mislocalisation and aggregation. Cell Stress Chaperones. 2017;22:893&#x2013;902. doi: 10.1007/s12192-017-0804-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0804-y</ArticleId><ArticleId IdType="pmc">PMC5655364</ArticleId><ArticleId IdType="pubmed">28560609</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuti M., Filosa G., Melzi V., Calandriello L., Dioni L., Bollati V., Bresolin N., Comi G.P., Barabino S., Nizzardo M. MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. Sci. Rep. 2018;8:1&#x2013;12. doi: 10.1038/s41598-018-28366-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28366-1</ArticleId><ArticleId IdType="pmc">PMC6031650</ArticleId><ArticleId IdType="pubmed">29973608</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanotto D., Zhang X., Alluin J., Zhang X., R&#xfc;ger J., Armstrong B., Rossi J., Riggs A., Stein C. A stress-induced response complex (SIRC) shuttles miRNAs, siRNAs, and oligonucleotides to the nucleus. Proc. Natl. Acad. Sci. USA. 2018;115:E5756&#x2013;E5765. doi: 10.1073/pnas.1721346115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1721346115</ArticleId><ArticleId IdType="pmc">PMC6016802</ArticleId><ArticleId IdType="pubmed">29866826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanata E., Th&#xfc;ne K., Xanthopoulos K., Ferrer I., Dafou D., Zerr I., Sklaviadis T., Llorens F. MicroRNA alterations in the brain and body fluids of humans and animal prion disease models: Current status and perspectives. Front. Aging Neurosci. 2018;10:220. doi: 10.3389/fnagi.2018.00220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00220</ArticleId><ArticleId IdType="pmc">PMC6064744</ArticleId><ArticleId IdType="pubmed">30083102</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer A., Medina S.J., Niu Y., Abrenica B., Manguiat K.J., Frost K.L., Philipson C.S., Sorensen D.L., Booth S.A. Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog. 2012;8:e1003002. doi: 10.1371/journal.ppat.1003002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003002</ArticleId><ArticleId IdType="pmc">PMC3493483</ArticleId><ArticleId IdType="pubmed">23144617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Diaz Z., Fang X., Hart M.P., Chesi A., Shorter J., Gitler A.D. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.J., Cansizoglu A.E., S&#xfc;el K.E., Louis T.H., Zhang Z., Chook Y.M. Rules for nuclear localization sequence recognition by karyopherin&#x3b2;2. Cell. 2006;126:543&#x2013;558. doi: 10.1016/j.cell.2006.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.049</ArticleId><ArticleId IdType="pmc">PMC3442361</ArticleId><ArticleId IdType="pubmed">16901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Si W., Ye S., Ren Z., Liu X., Wu Z., Li Y., Zhou J., Zhang S., Li Y., Deng R., et al. miR-335 promotes stress granule formation to inhibit apoptosis by targeting ROCK2 in acute ischemic stroke. Int. J. Mol. Med. 2019;43:1452&#x2013;1466. doi: 10.3892/ijmm.2019.4073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2019.4073</ArticleId><ArticleId IdType="pmc">PMC6365079</ArticleId><ArticleId IdType="pubmed">30747210</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luna N., Turon-Sans J., Cortes-Vicente E., Carrasco-Rozas A., Ill&#xe1;n-Gala I., Dols-Icardo O., Clarim&#xf3;n J., Lle&#xf3; A., Gallardo E., Illa I., et al. Downregulation of miR-335-5P in Amyotrophic Lateral Sclerosis Can Contribute to Neuronal Mitochondrial Dysfunction and Apoptosis. Sci. Rep. 2020;10:4308. doi: 10.1038/s41598-020-61246-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-61246-1</ArticleId><ArticleId IdType="pmc">PMC7062873</ArticleId><ArticleId IdType="pubmed">32152380</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Guida M., Guida M., Coppola C., De Mieri G., Cotrufo R. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene. 2012;508:35&#x2013;40. doi: 10.1016/j.gene.2012.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.07.058</ArticleId><ArticleId IdType="pubmed">22903028</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Manfellotto F., Fiorentino G., Annunziata A., Biffali E., Pannone R., Federico A. Wide-ranging analysis of MicroRNA profiles in sporadic amyotrophic lateral sclerosis using next-generation sequencing. Front. Genet. 2018;9:310. doi: 10.3389/fgene.2018.00310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00310</ArticleId><ArticleId IdType="pmc">PMC6102490</ArticleId><ArticleId IdType="pubmed">30154826</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G., Leigh P.N., Newbury S.F., Hafezparast M. An overview of MicroRNAs as biomarkers of ALS. Front. Neurol. 2019;10:186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C., Marzocchi C., Battistini S. MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells. 2018;7:219. doi: 10.3390/cells7110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110219</ArticleId><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P.R., Kazoka M., Wollff H., Shaw P.J., Kirby J. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front. Neurosci. 2018;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim J.R., Williams L.A., Limone F., San Juan I.G., Davis-Dusenbery B.N., Mordes D.A., Burberry A., Steinbaugh M.J., Gamage K.K., Kirchner R. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 2019;22:167&#x2013;179. doi: 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Chen W., Hong S.-T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Lambert-Smith I.A., Warraich S.T., Blair I.P., Saunders D.N., Hatters D.M., Yerbury J.J. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 2015;5:13416. doi: 10.1038/srep13416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13416</ArticleId><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel F., Gernoux G., Sun H., Stock R., Blackwood M., Brown R.H., Mueller C. Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Sci. Transl. Med. 2018;10:eaau6414. doi: 10.1126/scitranslmed.aau6414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau6414</ArticleId><ArticleId IdType="pubmed">30381409</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi S., Thammisetty S.S., Codron P., Rahimian R., Plourde K.V., Soucy G., Bareil C., Phaneuf D., Kriz J., Gravel C. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology. J. Clin. Investig. 2019;129:1581&#x2013;1595. doi: 10.1172/JCI123931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI123931</ArticleId><ArticleId IdType="pmc">PMC6436898</ArticleId><ArticleId IdType="pubmed">30667370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H.-N., Tjostheim S., DaSilva K., Taylor D., Zhao B., Rakhit R., Brown M., Chakrabartty A., McLaurin J., Robertson J. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J. Neurosci. 2012;32:8791&#x2013;8799. doi: 10.1523/JNEUROSCI.5053-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5053-11.2012</ArticleId><ArticleId IdType="pmc">PMC6622344</ArticleId><ArticleId IdType="pubmed">22745481</ArticleId></ArticleIdList></Reference><Reference><Citation>Im H.-I., Kenny P.J. MicroRNAs in neuronal function and dysfunction. Trends Neurosci. 2012;35:325&#x2013;334. doi: 10.1016/j.tins.2012.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2012.01.004</ArticleId><ArticleId IdType="pmc">PMC3565236</ArticleId><ArticleId IdType="pubmed">22436491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591:1489&#x2013;1507. doi: 10.1002/1873-3468.12646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12646</ArticleId><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Zhao W., Appel S.H. The role of regulatory T lymphocytes in amyotrophic lateral sclerosis. JAMA Neurol. 2018;75:656&#x2013;658. doi: 10.1001/jamaneurol.2018.0043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0043</ArticleId><ArticleId IdType="pubmed">29507936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>